This grant, the PRMRP Technology/Therapeutic Development Award (TTDA), is provided by the Department of Defense (DoD) to support the translation of promising preclinical research into tangible products. These products are intended for clinical applications, encompassing prevention, detection, diagnosis, treatment, or improving quality of life for conditions aligned with the FY22 PRMRP Topic Areas and Strategic Goals. A key focus is addressing the healthcare needs of military Service Members, Veterans, and their beneficiaries. While this award explicitly excludes funding for clinical trials, it does permit non-interventional clinical research studies. The aim is to develop impactful solutions that move beyond foundational research towards practical, clinical utility.
Opportunity ID: 338720
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-22-PRMRP-TTDA |
| Funding Opportunity Title: | DoD PRMRP Technology/Therapeutic Development Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 20 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Mar 16, 2022 |
| Last Updated Date: | Mar 16, 2022 |
| Original Closing Date for Applications: | May 27, 2022 |
| Current Closing Date for Applications: | May 27, 2022 |
| Archive Date: | Jun 26, 2022 |
| Estimated Total Program Funding: | $78,000,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: |
The PRMRP Technology/Therapeutic Development Award (TTDA) is a product-driven award mechanism intended to provide support for the translation of promising preclinical findings into products for clinical applications, including prevention, detection, diagnosis, treatment, or quality of life, for a disease or condition related to one of the FY22 PRMRP Topic Areas and one of the FY22 PRMRP Strategic Goals. Products in development should be responsive to the healthcare needs of military Service Members, Veterans, and/or beneficiaries. This award mechanism may not be used to conduct clinical trials; however, non-interventional clinical research studies are allowed. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
CDMRP Help Desk
Phone: 301-682-5507 Email: help@eBRAP.org Email:help@eBRAP.org |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 338720 Full Announcement-FY22 PRMRP TTDA -> W81XWH-22-PRMRP-TTDA-GG.pdf
Packages
| Agency Contact Information: | CDMRP Help Desk Phone: 301-682-5507 Email: help@eBRAP.org Email: help@eBRAP.org |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 12.420 | PKG00272614 | Mar 16, 2022 | May 27, 2022 | View |
Package 1
Mandatory forms
338720 RR_SF424_5_0-5.0.pdf
338720 AttachmentForm_1_2-1.2.pdf
338720 RR_PersonalData_1_2-1.2.pdf
338720 RR_KeyPersonExpanded_4_0-4.0.pdf
338720 RR_Budget_3_0-3.0.pdf
338720 PerformanceSite_4_0-4.0.pdf
Optional forms
338720 RR_SubawardBudget30_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
